230 related articles for article (PubMed ID: 37646422)
1. Human Mpox in People Living with HIV: Epidemiologic and Clinical Perspectives from Nigeria.
Iroezindu MO; Crowell TA; Ogoina D; Yinka-Ogunleye A
AIDS Res Hum Retroviruses; 2023 Nov; 39(11):593-600. PubMed ID: 37646422
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and predictors of human mpox outcome during the 2022 outbreak in Nigeria: a cohort study.
Ogoina D; Dalhat MM; Denue BA; Okowa M; Chika-Igwenyi NM; Yusuff HA; Christian UC; Adekanmbi O; Ojimba AO; Aremu JT; Habila KL; Oiwoh SO; Tobin EA; Johnson SM; Olaitan A; Onyeaghala C; Gomerep SS; Alasia D; Onukak AE; Mmerem J; Unigwe U; Falodun O; Kwaghe V; Awang SK; Sunday M; Maduka CJ; Na'uzo AM; Owhin SO; Mohammed AA; Adeiza MA;
Lancet Infect Dis; 2023 Dec; 23(12):1418-1428. PubMed ID: 37625431
[TBL] [Abstract][Full Text] [Related]
3. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics.
Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S;
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376
[TBL] [Abstract][Full Text] [Related]
4. Comparison of clinical course of Mpox among HIV-negative and HIV-positive patients: A 2022 cohort of hospitalized patients in Central Europe.
Kowalski J; Cielniak I; Garbacz-Łagożna E; Cholewińska-Szymańska G; Parczewski M
J Med Virol; 2023 Oct; 95(10):e29172. PubMed ID: 37861345
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Mpox Knowledge, Stigma, and Willingness to Vaccinate for Mpox: Cross-Sectional Web-Based Survey Among Sexual and Gender Minorities.
Torres TS; Silva MST; Coutinho C; Hoagland B; Jalil EM; Cardoso SW; Moreira J; Magalhaes MA; Luz PM; Veloso VG; Grinsztejn B
JMIR Public Health Surveill; 2023 Jul; 9():e46489. PubMed ID: 37459174
[TBL] [Abstract][Full Text] [Related]
6. Mpox in people with past infection or a complete vaccination course: a global case series.
Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM;
Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309
[TBL] [Abstract][Full Text] [Related]
7. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
Aden D; Zaheer S; Kumar R; Ranga S
J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of mpox positive, versus mpox negative, and mpox unsuspected clients from the Centre of Sexual Health, Public Health Service of Amsterdam, 20 May to 15 September 2022.
Siegenbeek van Heukelom ML; Jongen VW; Schouten J; Hoornenborg E; Bruisten S; Westerhuis B; Welkers MR; Vergunst CE; Prins M; Schim van der Loeff MF; de Vries HJC
J Eur Acad Dermatol Venereol; 2023 Sep; 37(9):1891-1896. PubMed ID: 37212540
[TBL] [Abstract][Full Text] [Related]
9. Lower rate of mpox vaccination hesitancy and medical consultation among Chinese men who have sex with men living with HIV in comparison with those living without HIV: A national observational study.
Zheng M; Du M; Yang G; Yao Y; Qian X; Zhi Y; Ma L; Tao R; Zhu Z; Zhou F; Dai S; Yang J; Liu M; Liu J
Hum Vaccin Immunother; 2023 Dec; 19(3):2290788. PubMed ID: 38054460
[TBL] [Abstract][Full Text] [Related]
10. Tecovirimat for the treatment of severe Mpox in Germany.
Hermanussen L; Brehm TT; Wolf T; Boesecke C; Schlabe S; Borgans F; Monin MB; Jensen BO; Windhaber S; Scholten S; Jordan S; Lütgehetmann M; Wiesch JSZ; Addo MM; Mikolajewska A; Niebank M; Schmiedel S
Infection; 2023 Oct; 51(5):1563-1568. PubMed ID: 37273167
[TBL] [Abstract][Full Text] [Related]
11. Mpox in Nigeria: Perceptions and knowledge of the disease among critical stakeholders-Global public health consequences.
Awoyomi OJ; Njoga EO; Jaja IF; Oyeleye FA; Awoyomi PO; Ibrahim MA; Saulawa MA; Galadima HB; Rowaiye AB; Olasoju TI; Idrisa JA; Olalere FDH; Olasoju MI; Adisa OH; Adetunji VE; Idemudia OO; Ezenduka EV; Oguttu JW
PLoS One; 2023; 18(3):e0283571. PubMed ID: 36996122
[TBL] [Abstract][Full Text] [Related]
12. Monkeypox Outbreak in Peru.
Ramírez-Soto MC
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374300
[TBL] [Abstract][Full Text] [Related]
13. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
[TBL] [Abstract][Full Text] [Related]
14. Mpox in people with advanced HIV infection: a global case series.
Mitjà O; Alemany A; Marks M; Lezama Mora JI; Rodríguez-Aldama JC; Torres Silva MS; Corral Herrera EA; Crabtree-Ramirez B; Blanco JL; Girometti N; Mazzotta V; Hazra A; Silva M; Montenegro-Idrogo JJ; Gebo K; Ghosn J; Peña Vázquez MF; Matos Prado E; Unigwe U; Villar-García J; Wald-Dickler N; Zucker J; Paredes R; Calmy A; Waters L; Galvan-Casas C; Walmsley S; Orkin CM;
Lancet; 2023 Mar; 401(10380):939-949. PubMed ID: 36828001
[TBL] [Abstract][Full Text] [Related]
15. A global update of mpox (monkeypox) in children.
Sam-Agudu NA; Martyn-Dickens C; Ewa AU
Curr Opin Pediatr; 2023 Apr; 35(2):193-200. PubMed ID: 36809304
[TBL] [Abstract][Full Text] [Related]
16. Monkeypox-Related Stigma and Vaccine Challenges as a Barrier to HIV Pre-Exposure Prophylaxis among Black Sexual Minority Men.
Turpin RE; Mandell CJ; Camp AD; Davidson Mhonde RR; Dyer TV; Mayer KH; Liu H; Coates T; Boekeloo BO
Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510557
[TBL] [Abstract][Full Text] [Related]
17. A plague passing over: Clinical features of the 2022 mpox outbreak in patients of color living with HIV.
Momin ZK; Lee A; Vandergriff TW; Bowling JE; Chamseddin B; Dominguez A; Hosler GA; Wang RC; Kitchell E
HIV Med; 2023 Oct; 24(10):1056-1065. PubMed ID: 37336551
[TBL] [Abstract][Full Text] [Related]
18. Mpox in a Couple Living with HIV: Relapse or Reinfection?
Rocha SQ; Fonsi M; Tancredi MV; Alencar HDR; Abbud A; da Silva MH
AIDS Res Hum Retroviruses; 2023 Nov; 39(11):610-615. PubMed ID: 37140474
[TBL] [Abstract][Full Text] [Related]
19. Mpox knowledge, behaviours and barriers to public health measures among gay, bisexual and other men who have sex with men in the UK: a qualitative study to inform public health guidance and messaging.
May T; Towler L; Smith LE; Horwood J; Denford S; Rubin GJ; Hickman M; Amlôt R; Oliver I; Yardley L
BMC Public Health; 2023 Nov; 23(1):2265. PubMed ID: 37978506
[TBL] [Abstract][Full Text] [Related]
20. Description of the first global outbreak of mpox: an analysis of global surveillance data.
Laurenson-Schafer H; Sklenovská N; Hoxha A; Kerr SM; Ndumbi P; Fitzner J; Almiron M; de Sousa LA; Briand S; Cenciarelli O; Colombe S; Doherty M; Fall IS; García-Calavaro C; Haussig JM; Kato M; Mahamud AR; Morgan OW; Nabeth P; Naiene JD; Navegantes WA; Ogundiran O; Okot C; Pebody R; Matsui T; Ramírez HL; Smallwood C; Tasigchana RFP; Vaughan AM; Williams GS; ; Mala PO; Lewis RF; Pavlin BI; le Polain de Waroux O
Lancet Glob Health; 2023 Jul; 11(7):e1012-e1023. PubMed ID: 37349031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
